```json
{
"content": [
{
"type": "paragraph",
"content": "The Thoracic Vascular Graft market encompasses medical devices used to treat thoracic aortic aneurysms, coarctations, and occlusive vascular diseases, enabling life-saving surgical interventions. With a global market size estimated at $1.2 billion in 2025, this sector is poised for robust growth outlook, driven by aging populations, rising prevalence of cardiovascular diseases, and technological advancements in endovascular repair. The market forecast projects a 6.5% CAGR from 2026 to 2033, reflecting significant industry expansion as demand for minimally invasive procedures surges."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Prosthetic Grafts", "Biologic/Biodegradable Grafts", "Others"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[180, 190, 200, 210, 220, 230, 245, 260, 275, 290, 305, 320, 335, 350], // Prosthetic Grafts
[50, 55, 60, 65, 70, 80, 90, 100, 110, 125, 140, 155, 170, 185], // Biologic/Biodegradable Grafts
[30, 32, 34, 36, 38, 40, 42, 45, 48, 50, 52, 54, 56, 58] // Others
]
}
},
{
"type": "paragraph",
"content": "Key forces shaping the Thoracic Vascular Graft market include innovations in bioabsorbable graft materials and regulatory tailwinds promoting safer, longer-lasting devices. North America remains the largest regional market due to high surgical adoption and advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by rising disposable incomes and expanding medical tourism. Strategic M&A activity and partnerships among key players further intensify competitive intensity, accelerating R&D in next-generation grafts. This dynamic landscape underscores the market’s resilience and potential for transformative industry expansion through 2033."
}
]
}
```
